LIBERVANT
LIVE

Serial Number

97207918

Owner

AQUESTIVE THERAPEUTICS, INC.

Attorney

Carrie Webb Olson

First Use Date

Apr 29, 2024

Filing Date

Jan 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LIBERVANT Trademark

Serial Number: 97207918 • Registration: 7746995

LIBERVANT is a trademark filed by AQUESTIVE THERAPEUTICS, INC. on January 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AQUESTIVE THERAPEUTICS, INC. (82 trademarks)

30 Technology Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

January 7, 2022

Registration Date

April 1, 2025

First Use Anywhere

April 29, 2024

First Use in Commerce

April 29, 2024

Published for Opposition

April 26, 2022

Goods & Services

Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsy, anxiety disorders, seizure disorders, sleep disorders, insomnia, alcohol, opiate and benzodiazepine withdrawal syndrome, muscle spasms, and psychiatric disorders; pharmaceutical preparations, namely, anticonvulsants, anti seizure medications, psychotropics, benzodiazepines, sedatives, muscle relaxants, and mood stabilizing medications

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 7, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 7, 2025 CNPR
ASSIGNED TO EXAMINER
Mar 7, 2025 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Nov 15, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 14, 2024 AITU
USE AMENDMENT FILED
Sep 13, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 13, 2024 EISU
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 26, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 4 GRANTED
May 14, 2024 EX4G
SOU EXTENSION 4 FILED
May 14, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2023 EXRA
SOU EXTENSION 3 GRANTED
Nov 13, 2023 EX3G
SOU EXTENSION 3 FILED
Nov 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2023 EXRA
SOU EXTENSION 2 GRANTED
May 30, 2023 EX2G
SOU EXTENSION 2 FILED
May 30, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
May 30, 2023 EEXT
ASSIGNED TO EXAMINER
Feb 13, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 28, 2022 EX1G
SOU EXTENSION 1 FILED
Nov 28, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 28, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 25, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 21, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 14, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2022 NWOS
NEW APPLICATION ENTERED
Jan 11, 2022 NWAP